Twist Bioscience Corporation TWST Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Twist Bioscience Corporation in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Twist Bioscience Corporation's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Twist Bioscience Corporation's accrued expenses?
- Twist Bioscience Corporation (TWST) reported accrued expenses of $27M in Q1 2026.
- How has Twist Bioscience Corporation's accrued expenses changed year-over-year?
- Twist Bioscience Corporation's accrued expenses increased by 8.4% year-over-year, from $24.92M to $27M.
- What is the long-term trend for Twist Bioscience Corporation's accrued expenses?
- Over 5 years (2020 to 2025), Twist Bioscience Corporation's accrued expenses has grown at a 15.9% compound annual growth rate (CAGR), from $14.95M to $31.29M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.